Soap Note For Urinary Tract Infection

A SOAP note for urinary tract infection provides a structured, evidence‑based framework that helps clinicians document assessment, diagnosis, and management of patients with UTI, ensuring clear communication and optimal care. This format aligns with standard medical documentation, supports interdisciplinary collaboration, and enhances patient safety by capturing critical clinical details in a concise, logical sequence.

Understanding the SOAP Framework in UTI Documentation

What is a SOAP Note?

A SOAP note is a standardized method of recording patient encounters, dividing the information into four distinct sections:

1. Subjective – the patient’s reported symptoms, concerns, and history.
2. Objective – measurable, observable data gathered during the encounter.
3. Assessment – the clinician’s clinical judgment, diagnosis, and interpretation of the data.
4. Plan – the proposed interventions, prescriptions, follow‑up, and patient education.

When applied to a soap note for urinary tract infection, each section must address the unique aspects of urinary pathology, diagnostic criteria, and treatment protocols.

Why Use SOAP for UTI?

• Clarity: Enables rapid retrieval of key information by physicians, nurses, and allied health staff.
• Consistency: Facilitates uniform documentation across different settings (clinic, emergency department, inpatient).
• Legal Protection: Provides a clear audit trail that can be referenced in case of disputes or quality reviews.
• Quality Improvement: Allows aggregation of data for outcome tracking and research on UTI management.

Crafting Each Section for a Urinary Tract Infection

Subjective – Capturing the Patient’s VoiceThe Subjective section should include:

• Onset and duration of symptoms (e.g., dysuria started 2 days ago).
• Nature of symptoms (painful urination, frequency, urgency, nocturia, flank pain).
• Associated signs such as fever, chills, or flank tenderness.
• Past medical history relevant to urinary health (previous UTIs, kidney stones, diabetes). - Risk factors (sexual activity, catheter use, recent instrumentation).
• Current medications and allergies.

Example: “I’ve been feeling a burning sensation when I pee for the past three days, and I’m getting up to urinate every hour, even at night. I also noticed a low‑grade fever yesterday.”

Objective – Objective Data and FindingsThe Objective section must present measurable or observable information:

• Vital signs: Temperature, heart rate, blood pressure.
• Physical examination findings: Costovertebral angle tenderness, suprapubic tenderness, urine appearance.
• Laboratory results: Urinalysis (positive nitrite, leukocyte esterase), urine culture results, creatinine levels.
• Imaging findings (if performed): Ultrasound or CT scan results.
• Response to prior therapy (if any).

Example: “Temperature 38.2 °C, heart rate 102 bpm. Suprapubic tenderness noted on palpation. Urinalysis shows 2+ leukocytes, positive nitrite, and microscopic hematuria.”

Assessment – Clinical Interpretation

In the Assessment section, the clinician synthesizes the data to arrive at a diagnosis and severity classification. Key elements include:

• Diagnostic criteria for UTI (e.g., typical symptoms + positive urinalysis).
• Classification: Uncomplicated cystitis, complicated cystitis, pyelonephritis, urosepsis.
• Severity assessment: Based on systemic signs, lab values, and risk factors.
• Differential diagnoses considered and ruled out.
• Prognostic considerations: Risk of recurrence, potential for complications.

Example: “The patient meets criteria for complicated cystitis given fever, flank pain, and risk factor of recent catheterization. No evidence of renal obstruction on ultrasound.”

Plan – Structured Management Roadmap

The Plan section outlines actionable steps, ensuring all parties understand next steps:

1. Pharmacologic therapy – antibiotic selection, dosage, route, duration.
2. Non‑pharmacologic measures – hydration, bladder training, avoidance of irritants.
3. Diagnostic follow‑up – repeat urine culture after therapy, imaging if indicated.
4. Patient education – signs of worsening infection, when to seek care.
5. Referral – to urology or infectious disease if recurrent or refractory.
6. Documentation – specify coding (ICD‑10: N39.0) and billing considerations.

Example: “Prescribe nitrofurantoin 100 mg PO BID for 5 days. Advise increased fluid intake (≥2 L/day). Schedule urine culture 7 days after completion of therapy. Educate patient on early symptom recognition and advise follow‑up if symptoms persist beyond 48 hours after therapy.”

Detailed SOAP Note Example for a UTI Case

Below is a fully fleshed‑out soap note for urinary tract infection illustrating each component in practice.

Subjective

• Chief complaint: “Burning urination and frequent urination for 4 days.”
• History of present illness: 32‑year‑old female, no prior UTIs, sexually active, reports 3 episodes of intercourse in the past week. Denies flank pain, fever, or vaginal discharge. Reports low‑grade fever (37.8 °C) measured at home.
• Past medical history: Controlled asthma, no diabetes.
• Medications: Albuterol inhaler PRN.
• Allergies: Penicillin – rash.
• Social history: Non‑smoker, occasional wine.

Objective- Vitals: T 37.8 °C, HR 96 bpm, BP 118/72 mmHg, RR 16/min.

• General: Alert, oriented.
• HEENT: No scleral injection.
• Cardiovascular: Regular rate and rhythm.
• Respiratory: Clear to auscultation.
• Abdomen: Soft, non‑tender.
• Genitourinary: Positive suprapubic tenderness, no costovertebral angle tenderness.
• Urinalysis: pH

Objective (Continued)

• Urinalysis: pH 6.0, positive leukocyte esterase, positive nitrites, specific gravity 1.025.
• Microscopy: 25-30 WBC/hpf, 5-10 RBC/hpf, rare squamous epithelial cells, abundant Gram-negative bacilli.
• Urine culture: >100,000 CFU/mL of Escherichia coli sensitive to nitrofurantoin, trimethoprim-sulfamethoxazole, and ciprofloxacin.
• Vaginal exam: No discharge, no cervical motion tenderness.
• Pelvic exam: Mild erythema of urethral meatus.

Assessment

• Diagnosis: Uncomplicated cystitis (ICD-10: N39.0).
• Rationale: Symptomatic patient (dysuria, frequency) with classic urinalysis findings (leukocyte esterase, nitrites, pyuria) and positive culture for common uropathogen. No systemic signs (fever <38°C, stable vitals), flank pain, or obstruction on ultrasound.
• Classification: Uncomplicated cystitis (non-pregnant, no anatomic/functional abnormalities, no recent catheterization).
• Severity: Mild (localized symptoms, afebrile, no hemodynamic instability).
• Differential diagnoses: Vaginitis (ruled out by exam), urethritis (unlikely without discharge), interstitial cystitis (chronicity not present).
• Prognosis: Excellent with prompt antibiotic therapy; low recurrence risk given no prior history.

Plan

1. Pharmacologic therapy:
   • Nitrofurantoin 100 mg PO BID for 5 days (first-line for uncomplicated cystitis; avoids penicillin allergy).
   • Avoid TMP-SMX due to local resistance patterns; reserve for alternatives if needed.
2. Non-pharmacologic measures:
   • Hydration: ≥2 L water daily to promote urine flow.
   • Avoid bladder irritants: Caffeine, alcohol, and acidic juices for 7 days.
   • Cranberry juice (optional evidence for prevention).
3. Diagnostic follow-up:
   • Symptom reassessment in 48 hours; if unresolved, consider imaging or alternative diagnosis.
   • Repeat urine culture only if symptoms persist >7 days post-therapy.
4. Patient education:
   • Complete full course even if symptoms resolve.
   • Return immediately if fever, flank pain, or hematuria develops.
   • Sexual activity: No restriction, but urinate post-coitus to reduce recurrence risk.
5. Referral: None indicated (no recurrent/refractory features).
6. Documentation: Code N39.0; bill for E/M visit and urinalysis/culture.

Conclusion:
This SOAP note exemplifies a structured approach to uncomplicated cystitis, integrating clinical findings, diagnostics, and evidence-based management. By clearly documenting the assessment, rationale, and actionable plan, clinicians ensure continuity of care, reduce diagnostic ambiguity, and empower patients through targeted education. Adherence to such frameworks optimizes outcomes, minimizes complications, and supports efficient healthcare delivery.